PYPD Reports Q4 Net Loss $8.5M, ($0.41) EPS; Advances D-PLEX₁₀₀ Commercialization, Sees FDA Rolling NDA Submission Q1 2026
PolyPid Ltd. Ordinary Shares · Now $5.07
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS